Cubist Pharmaceuticals, Inc. (CBST) Completes Acquisition Of Calixa Therapeutics, Inc.
12/17/2009 9:50:44 AM
More...
|
Cubist Pharmaceuticals, Inc. (CBST) (JOBS) to Acquire Calixa Therapeutics, Inc. (JOBS) for $402.5 Million
12/14/2009 6:39:31 AM
More...
|
Calixa Therapeutics, Inc. Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections
6/30/2009 8:49:04 AM
More...
|
Calixa Therapeutics, Inc. Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
3/24/2009 8:42:01 AM
More...
|